Related Experiment Video
Updated: Feb 6, 2026

Production and Measurement of Organic Particulate Matter in a Flow Tube Reactor
Published on: December 15, 2018
Polymer conjugates as anticancer nanomedicines
1Centre for Polymer Therapeutics, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3XF, UK. Duncanr@cf.ac.uk
Abstract:
The transfer of polymer-protein conjugates into routine clinical use, and the clinical development of polymer-anticancer-drug conjugates, both as single agents and as components of combination therapy, is establishing polymer therapeutics as one of the first classes of anticancer nanomedicines. There is growing optimism that ever more sophisticated polymer-based vectors will be a significant addition to the armoury currently used for cancer therapy.
More Related Videos
Related Concept Videos
09:10Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging
04:40Electrostatic Method to Remove Particulate Organic Matter from Soil
08:57Improving Infrared Spectroscopy Characterization of Soil Organic Matter with Spectral Subtractions
13:29Production and Measurement of Organic Particulate Matter in a Flow Tube Reactor
09:46Production and Measurement of Organic Particulate Matter in the Harvard Environmental Chamber
09:38Understanding Dissolved Organic Matter Biogeochemistry Through In Situ Nutrient Manipulations in Stream Ecosystems

